Caregiving Crisis: AI Startup Tackles Growing Needs for Cancer & Senior Care
The demands of caregiving are escalating across the United States, driven by demographic shifts and advances in medical treatment. Neal K. Shah experienced this firsthand while navigating his family’s healthcare challenges, leading him to co-found CareYaya Health Technologies, a company aiming to address the growing need for accessible and affordable care support.
A Looming Caregiving Crisis
Shah’s personal experiences – supporting his grandfather with dementia and kidney failure, and later, his wife through cancer treatment – highlighted the intensity and complexity of caregiving. He ultimately shut down a $250 million hedge fund to become a full-time caregiver for his wife for a couple of years, recognizing the significant impact dedicated care could have on her outcome. His journey revealed systemic flaws in the care industry and inspired a search for innovative solutions.
The Changing Face of Caregiving
The need for caregivers is increasing as the population ages. AARP data indicates that the “caregiver support ratio” – the number of potential caregivers to those needing care – is shrinking, moving from 6 or 7 persons aged 45 to 64 for every person over 80, to a projected 3:1 in the current decade. More than 40% of unpaid caregivers are now men, reflecting a shift from traditional gender roles.
New Therapies, Increased Needs
Advances in cancer treatment, particularly with bispecific antibodies and CAR T-cell therapy, are extending patients’ lives but also increasing the complexity of care. These therapies often require vigilant monitoring for adverse effects like cytokine release syndrome (CRS) and immune effector cell–associated neurotoxicity syndrome (ICANS). Caregivers play a crucial role in observing symptoms and contacting the care team.
CareYaya’s Approach
CareYaya aims to bridge the gap by connecting families with health care students seeking flexible employment. The company, operating in 10 states plus Washington, DC, focuses on providing support for symptom and medication monitoring, while avoiding tasks requiring extensive licensing. CareYaya companions can also assist with technology, ensuring digital monitoring systems function properly. The company was named to the third CancerX Accelerator Cohort in January 2026 for its innovative approach.
Looking Ahead
Demand for caregivers is expected to grow significantly as eligibility for therapies like bispecific antibodies expands, with over 300 products currently in development. Health systems are increasingly moving these treatments to outpatient settings to improve access and reduce costs, further increasing the reliance on family caregivers. Experiments with paid caregivers are underway, and the need for reliable support is becoming a critical factor in treatment decisions.
Frequently Asked Questions
What is CareYaya?
CareYaya is an AI-powered start-up that connects families with health care students for flexible, part-time caregiving support, focusing on tasks like symptom monitoring and medication reminders.
What is the “caregiver support ratio”?
The “caregiver support ratio” measures the number of potential caregivers (ages 45-64) available for each person over age 80; it is collapsing from 6 or 7 to 1 to 3 to 1 in the current decade.
What role do caregivers play in bispecific antibody therapy?
Caregivers are essential in monitoring patients receiving bispecific antibodies for adverse effects like cytokine release syndrome (CRS) and immune effector cell–associated neurotoxicity syndrome (ICANS), and contacting the care team when necessary.
As cancer treatments evolve and the population ages, how will communities adapt to meet the growing demand for accessible and affordable caregiving solutions?